Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: Report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology

Volumn 54, Issue 10, 2000, Pages 1886-1893

  Glantz, M J ^a,b   Cole, B F ^a,b   Forsyth, P A ^a   Recht, L D ^a,c   Wen, P Y ^a,d   Chamberlain, M C ^a,e   Grossman, S A ^a,f   Cairncross, J G ^a  

^a AMERICAN ACADEMY OF NEUROLOGY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e KAISER PERMANENTE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; VALPROATE SEMISODIUM;

ANTICONVULSANT THERAPY; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MELANOMA; MENINGIOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SEIZURE;

EID: 0034705172     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.10.1886     Document Type: Article

References (85)

1. Kvam DA, Loftus CM, Copeland B, et al. Seizures during the immediate postoperative period. Neurosurgery 1983;12:14-17.
2. Deutschman CS, Haines SJ. Anticonvulsant prophylaxis in neurological surgery. Neurosurgery 1985;17:510-517.
3. Cohen N, Strauss G, Lew R, et al. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988;6:1621-1624.
4. Posner JB. Neurologie complications of cancer. Philadelphia: FA Davis, 1995.
5. Delattre J, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988;38:194-198.
6. Taylor LP, Posner JB. Phenobarbital rheumatism in patients with brain tumor. Ann Neurol 1989;25:92-94.
7. Khe HX, Delattre JY, Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology 1990;40:1144-1145.
8. Borg MF, Probert JC, Zwi LJ. Is phenytoin contraindicated in patients receiving cranial irradiation? Australas Radiol 1995; 39:42-46.
9. Cockey GH, Amann ST, Reents SB, et al. Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin. Am J Clin Oncol 1996;19:32-34.
10. Lehmann DF, Hurteau TE, Newman N, et al. Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors. Clin Pharmacol Ther 1997;62:225-229.
11. Mahaley MS, Dudka L. The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 1981;16:399-401.
12. Hagen NA, Cirrincione C, Thaler HT, et al. The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990;40:158-160.
13. Hung S, Hilsenbeck S, Feun L. Seizure prophylaxis with phenytoin in patients with brain metastases. Proc Am Soc Clin Oncol 19991;10:A1151. Abstract.
14. Moots PL, Maciunas RJ, Eisert DR, et al. The course of seizure disorders in patients with malignant gliomas. Arch Neurol 1995;52:717-724.
15. Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985-991.
16. Forsyth PA, Weaver S, Fulton D, et al. A prospective randomized study of prophylactic anticonvulsants in patients with primary or metastatic brain tumors and without prior seizures. J Neurooncol 2000 (in press).
17. Haque N, Thrasher K, Werk E. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. J Clin Endocrinol Metab 1972;34:44-50.
18. Gambertoglio JG, Holford NH, Kapusnik JE, et al. Disposition of total unbound prednisolone in renal transplant patients receiving anticonvulsants. Kidney Int 1984;25:119-123.
19. Chalk JB, Ridgeway K, Brophy T, et al. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 1984;47: 1087-1090.
20. Dropcho EJ, Soong S. Steroid-induced weakness in patients with primary brain tumors. Neurology 1991;41:1235-1239.
21. Wassner SJ, Malekzadem MH, Pennisi AJ, et al. Allograft survival in patients receiving anticonvulsant medications. Clin Nephrol 1977;8:293-297.
22. Reich SD, Bachur NR. Alterations in adriamycin efficacy by phenobarbital. Cancer Res 1976;36:3803-3806.
23. Warren RD, Bender AR. Drug interactions with antineoplastic agents. Cancer Treat Rep 1977;61:1231-1241.
24. Gilbert MR, Grossman SA, Mikkelson T, et al. The impact of anticonvulsants on CPT-11 dose in patients with recurrent malignant glioma. Neurooncology 1999;1:313. Abstract.
25. Levin VA, Stearns J, Byrd A, et al. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chlorethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), on the plasma pharmacokinetics and biotransformation of BCNU. J Pharmacol Exp Ther 1979;208:1-6.
26. Muller PJ, Tator CH, Bloom M. The effect of phenobarbital on the toxicity and tumoricidal activity of CCNU in a murine brain tumor model. J Neurosurg 1980;52:359-366.
27. Workman P, Bleehen NM, Wiltshire CR. Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. Br J Cancer 1980;41:302-304.
28. Fitzsimmons WE, Ghalie R, Kaizer H. The effect of hepatic enzyme inducers on busulfan neurotoxicity. Cancer Chemother Pharmacol 1990;27:226-228.
29. Baker DK, Relling MV, Pui C-H, et al. Increased teniposide clearance with concomitant anticonvulsant therapy. J Clin Oncol 1992;10:311-315.
30. Friedman AH, Ashley DM, Kerby T, et al. Topotecan treatment of adults with primary malignant glioma. Proc Am Soc Clin Oncol 1998;17:390A. Abstract.
31. Chang TK, Chen G, Waxman DJ. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism. J Pharmacol Exp Ther 1995;274: 270-275.
32. Fetell MR, Grossman SA, Fisher JD, et al. Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. J Clin Oncol 1997;15:3121-3128.
33. Grossman SA, Hochberg F, Fisher J, et al. Increased 9-aminocampothecin dose requirements in patients on anticonvulsants. Cancer Chemother Pharmacol 1998;42:118-126.
34. Chang SM, Kuhn JG, Rizzo J, et al. Phase I study of paclitaxel in patients with recurrent malignant gliomas: a North American Brain Tumor Consortium report. J Clin Oncol 1998; 16: 2188-2194.
35. Glantz MJ, Kim L, Choy H, Akerley W. Concurrent chemotherapy and radiotherapy in patients with brain tumors. Oncology 1999;13:78-82.
36. Finchum RW, Schottelius DD. Decreased phenytoin levels in antineoplastic therapy. Ther Drug Monit 1979;1:277-283.
37. Perucca E. Pharmacokinetic interactions with antiepileptic drugs. Clin Pharmacokinet 1982;7:57-84.
38. Sylvester RK, Lewis FB, Caldwell KC, et al. Impaired phenytoin bioavailability secondary to cisplatinum, vinblastine and bleomycin. Ther Drug Monit 1984;6:302-305.
39. Neef C, de Voogd-van der Straaten J. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 1988;43:372-375.
40. Jarosinski PF, Moslow JA, Alexander MS, et al. Altered phenytoin clearance during intensive treatment for acute lymphoblastic leukemia. J Pediatr 1988;112:996-999.
41. Grossman SA, Sheilder VR, Gilbert MR. Decreased phenytoin levels in patients receiving chemotherapy. Am J Med 1989;87: 505-510.
42. Lackner TE. Interaction of dexamethasone with phenytoin. Pharmacotherapy 1991;11:344-347.
43. Ghosh C, Lazarus HM, Hewlett JS, et al. Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors. J Neurooncol 1992;12:25-32.
44. Rabinowicz AL, Hinton DR, Dyck P, et al. High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs. Epilepsia 1995;36:513-515.
45. Gattis WA, May DB. Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review. Ann Pharmacother 1996;30:520-526.
46. Sorrell TC, Forbes IJ. Depression of immune competence by phenytoin and carbamazepine: studies in vivo and in vitro. Clin Exp Immunol 1975;20:273-285.
47. Neuwelt EA, Kikuchi K, Hill S, et al. Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity. Cancer 1983;51:248-255.
48. Bardana EJ, Gabourel JD, Davies GH, et al. Effects of phenytoin on man's immunity: evaluation of changes in serum immunoglobulins, complement, and anti-nuclear antibody. Am J Med 1983;74:289-296.
49. Kikuchi K, McCormick CI, Neuwelt EA. Immunosuppression by phenytoin: implications for altered immune competence in brain tumor patients. J Neurosurg 1984;61:1085-1090.
50. Davis F, Surawicz T, Barlas S, Propp J. Central Brain Tumor Registry of the United States. Chicago: CBTRUS, 1997.
51. Posner JB. Management of brain metastases. Rev Neurol (Paris) 1992;148:477-487.
52. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
53. Simonescu MD. Metastatic tumors of the brain. A follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960;17:361-373.
54. Zimm S, Wampler GL, Stablein D, et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981;48:384-394.
55. Gilbert MR, Grossman SA. Incidence and nature of neurologic problems in patients with solid tumors. Am J Med 1986;81: 951-954.
56. Glantz M, Recht L. Epilepsy in the cancer patient. In: Vinken PJ, Bruyn GW, eds. Neuro-oncology. Part III. Neurological disorders in systemic cancer. Handbook of clinical neurology. Vol. 69. Amsterdam: Elsevier Publishing, 1997:9-18.
57. Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol 1983;1:313-317.
58. Dent S, Bociek G. Prophylactic anticonvulsants for cancer patients with newly diagnosed brain metastases. Proc Am Soc Clin Oncol 1996;15:529. Abstract.
59. Boarini DJ, Beck DW, VanGilder JC. Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 1985;16:290-292.
60. Franceschetti S, Binelli S, Casazza M, et al. Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir 1990;103:47-51.
61. North JB, Penhall RK, Hanieh A, et al. Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 1983;58: 672-677.
62. Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461-2465.
63. Greig NH, Ries LG, Yanick R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990;82:1621-1624.
64. Desmeules M, Middlesen T, Mao Y. Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst 1992;84:442-445.
65. Devesa SS, Bot WJ, Stone BJ, et al. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87:175-181.
66. Matthew E, Sherwin AL, Welner SA, et al. Seizures following intracranial surgery: incidence in the first post-operative week. Can J Neurol Sci 1980;7:285-290.
67. Foy PM, Chadwick DW, Rajgopalan N, et al. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy. J Neurol Neurosurg Psychiatry 1992;55:753-757.
68. Lee S-T, Lui T-N, Chang C-N, et al. Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 1989;31:361-364.
69. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke - summary statement. Neurology 1996;47: 835-839.
70. American Society of Clinical Oncology Ad Hoc Non-Small-Cell Lung Cancer Expert Panel. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997;15:2996-3018.
71. Rosner B. Fundamentals of biostatistics. 4th ed. Belmont, CA: Wadsworth, 1995.
72. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1681-1692.
73. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
74. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35: 1-39.
75. Landau J, Baulac M, Durand G, et al. Impairment of consciousness induced by valproate treatment following neurosurgical operation. Acta Neurochir 1993;125:92-96.
76. Leppik IE. Compliance during treatment of epilepsy. Epilepsia 1988;29(suppl 2):S79-S84.
77. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450-455.
78. Deutschman CS, Haines SJ. Anticonvulsant prophylaxis in neurological surgery. Neurosurgery 1985;17:510-517.
79. Rasmussen T, Blundell J. Epilepsy and brain tumor. Clin Neurosurg 1959;7:138-158.
80. Berger MS, Ghatan S, Haglund MM, et al. Low grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg 1993;79:62-69.
81. Giles FA, Sobell E, Leviton A, et al. Epidemiology of seizures in children with brain tumors. J Neurooncol 1992;12:53-68.
82. Kuijlen JMA, Teernstra OPM, Kessels AGH, et al. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 1996;5:291-298.
83. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593-600.
84. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blinded study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
85. Temkin NR, Haglund MM, Winn HR. Post-traumatic seizures. In: Youmans JR, ed. Neurological surgery. 4th ed. Philadelphia: WB Saunders, 1996:1834-1839.